Comparative effectiveness of clinically used light sources for cutaneous protoporphyrin IX-based photodynamic therapy

Journal of Cosmetic and Laser Therapy

Volumn 13, Issue 2, 2011, Pages 63-68

  Sayre, Robert M ^a,b   Dowdy, John C ^b   Gottschalk, Ronald W ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Rapid Precision Testing Laboratories   (United States)

^c Galderma Laboratories   (United States)

Author keywords

index for PpIX; intense pulsed light; Kerastick ; Levulan ; Metvixia ; PAE coeffi cient; photodynamic therapy; protoporphyrin IX; total effective fl uence

Indexed keywords

PROTOPORPHYRIN;

ABSORPTION SPECTROSCOPY; ALGORITHM; ARTICLE; COMPARATIVE STUDY; HUMAN; LIGHT; LIGHT IRRADIANCE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

HUMANS; LASERS; LIGHT; OPTICAL PROCESSES; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS;

EID: 79952642519     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764172.2011.564628     Document Type: Article

References (16)

1. Moseley H. Total effective fluence: A useful concept in pho-todynamic therapy. Lasers Med Sci. 1996;11:139-43. (Pubitemid 26387708)
2. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen' s disease by photodynamic therapy. Br J Dermatol. 2000; 143:767-72.
3. Morton CA, Whitehurst C, Moseley H, Moore JV, MacKie RM. Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci. 1995;10:165-71. (Pubitemid 26146263)
4. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbot-son SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003; 19:134-41. (Pubitemid 36889801)
5. Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, et al. Photodynamic therapy of superfi cial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylenediaminetetraacetic acid: A comparison of two light sources. Photochem Photobiol. 2000;71:724-9.
6. Shikowitz MJ. Comparison of pulsed and continuous wave light in photodynamic therapy of papillomas: An experimental study. Laryngoscope. 1992;102:300-10.
7. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superfi cial skin lesions. Acta Derm Venereol. 1994;74:117-9. (Pubitemid 24102471)
8. Eadie E, Miller P, Goodman T, Moseley H. Time-resolved measurement shows a spectral distribution shift in an intense pulsed light system. Lasers Med Sci. 2009;24:35-43.
9. Clarkson DM, Gill D, Odeke M. A time resolved intense pulsed light spectral analysis system. Lasers Med Sci. 2008;23:59-64. (Pubitemid 350196868)
10. Town G, Ash C, Eadie E, Moseley H. Measuring key parameters of intense pulsed light (IPL) devices. J Cosmet Laser Ther. 2007;9:148-60. (Pubitemid 47347213)
11. Chignell CF, Sik RH, Bilski PJ. The photosensitizing potential of compact fluorescent vs incandescent light bulbs. Photochem Photobiol. 2008;84(5):1291-3.
12. Tsoukas MM, Gonzalez S, Flotte TJ, Anderson RR, Sherwood ME, Kollias N. Wavelength and fluence effect on vascular damage with photodynamic therapy on skin. J Invest Dermatol. 2000;114:303-8. (Pubitemid 30417765)
13. Kollias N, Baqer A, Sadiq I, Sayre RM. In vitro and in vivo ultraviolet-induced alterations of oxy-and deoxyhemoglobin. Photochem Photobiol. 1992;56:223-7.
14. Zelickson BD. Mechanism of action of topical aminolevulinic acid. In: Goldman MP, editor. Photodynamic therapy, procedures in cosmetic dermatology. Philadelphia: Elsevier Saunders; 2005. p. 1-11.
15. Nootheti PK, Goldman MP. Aminolevulinic acid-photo-dynamic therapy for photorejuvenation. Dermatol Clin. 2007;25:35-45.
16. Morton CA. Photodynamic therapy for nonmelanoma skin cancer-and more? Arch Dermatol. 2004;140:116-20. (Pubitemid 38090279)